MarketCap
Facebook
X
TelegramIntersect ENT, Inc. Book Value 2011-2026 | XENT
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Intersect ENT, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 550 M | 171 M | 92 M | 103 M | 35.9 M | 63.9 M | 61 M | 72.8 M | 24.1 M | 12.6 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 550 M | 12.6 M | 119 M |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
-38.6 M | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
1.82 B | $ 39.03 | -0.61 % | $ 5.82 K | USA |
 |
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M |  China |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
217 M | $ 8.1 | 3.58 % | $ 582 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
17.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.53 B | $ 9.61 | 2.23 % | $ 1.3 B | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | $ 4.1 | 2.76 % | $ 153 M |  France |
 |
Electromed
ELMD
|
43.2 M | $ 24.46 | 2.02 % | $ 207 M | USA |
 |
CONMED Corporation
CNMD
|
1.03 B | $ 43.13 | -0.43 % | $ 1.34 B | USA |
 |
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | USA |
 |
FONAR Corporation
FONR
|
146 M | $ 18.54 | 0.22 % | $ 122 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
129 M | $ 29.55 | -0.94 % | $ 1.36 B | USA |
 |
Apyx Medical Corporation
APYX
|
26.9 M | $ 3.29 | 3.78 % | $ 114 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
81.2 M | $ 0.52 | -0.99 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
17.6 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Cytosorbents Corporation
CTSO
|
11.1 M | $ 0.79 | -1.19 % | $ 43 M | USA |
 |
Align Technology
ALGN
|
3.85 B | $ 182.25 | -0.21 % | $ 13.6 B | USA |
 |
Inari Medical
NARI
|
417 M | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
169 M | $ 4.01 | 8.38 % | $ 849 M | USA |
 |
BIOLASE
BIOL
|
1.96 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
86.7 B | $ 113.33 | -0.22 % | $ 197 B | USA |
 |
NuVasive
NUVA
|
2.22 B | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
231 M | - | - | $ 217 M | USA |
 |
BioSig Technologies
BSGM
|
-1.42 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 72.95 | -1.22 % | $ 108 B | USA |
 |
InMode Ltd.
INMD
|
683 M | $ 13.55 | -0.37 % | $ 876 M | Israel |
 |
IRIDEX Corporation
IRIX
|
9.52 M | $ 1.43 | - | $ 23.1 M | USA |
 |
IRadimed Corporation
IRMD
|
86.8 M | $ 105.71 | 1.36 % | $ 1.34 B | USA |
 |
Helius Medical Technologies
HSDT
|
2.35 M | $ 2.27 | 14.65 % | $ 1.38 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 13.13 | 0.84 % | $ 1.97 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
10.3 B | $ 85.6 | 0.39 % | $ 50.1 B | USA |